Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Equity Ratio (2016 - 2025)

CorMedix's Equity Ratio history spans 13 years, with the latest figure at 0.49 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 31.13% year-over-year to 0.49; the TTM value through Dec 2025 reached 0.49, down 31.13%, while the annual FY2025 figure was 0.49, 31.13% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.49 at CorMedix, down from 0.5 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.95 in Q1 2021 and bottomed at 0.49 in Q4 2025.
  • The 5-year median for Equity Ratio is 0.89 (2022), against an average of 0.83.
  • The largest YoY upside for Equity Ratio was 20.95% in 2021 against a maximum downside of 89.67% in 2021.
  • A 5-year view of Equity Ratio shows it stood at 0.91 in 2021, then fell by 2.56% to 0.89 in 2022, then rose by 2.54% to 0.91 in 2023, then dropped by 21.72% to 0.71 in 2024, then tumbled by 31.13% to 0.49 in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Equity Ratio are 0.49 (Q4 2025), 0.5 (Q3 2025), and 0.87 (Q2 2025).